Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on August 26, 2025
The Hemp Doctor’s Kayo Line Delivers a Sweet Knockout with New Delta 9 Krispy Bites
GlobeNewswire
·
August 26, 2025
MOORESVILLE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor adds the latest contender to its high-potency edible Kayo line: the Kayo Delta 9 Krispy Bites. Packed with nostalgia, flavor, and a knockout dose of Delta 9 THC, these chewy marshmallow …
Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032
GlobeNewswire
·
August 26, 2025
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has entered a groundbreaking partnership with LUNR Aerospace to develop AI-driven drug repurposing initiatives …
Traliant Introduces New Fraud, Waste and Abuse in Healthcare Training to Protect Organizations from Costly Violations
GlobeNewswire
·
August 26, 2025
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Traliant, a leader in online compliance training, today announced its new course, Fraud, Waste and Abuse in Healthcare, designed to help healthcare organizations that accept public funds prevent costly violations …
FAMU College of Pharmacy Alumnus and Industry Pioneer Stan Loomis Inducted into Gallery of Distinction and Keynoted the 2025 White Coat Ceremony
GlobeNewswire
·
August 26, 2025
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation's leading compound pharmacies, announce today that co-founder Stan Loomis was inducted into the Florida A…
Omada Health to Participate in Upcoming Investor Conference
GlobeNewswire
·
August 26, 2025
SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference, …
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
GlobeNewswire
·
August 26, 2025
THE VILLAGES, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Ellis Island Honors Society has recognized Dr. Shai Efrati as a 2025 Ellis Island Medal of Honor recipient, celebrating his pioneering contributions to hyperbaric oxygen therapy and years of service …
PolarityBio Completes Enrollment in the Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
GlobeNewswire
·
August 26, 2025
SALT LAKE CITY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular therapy, today announced the …
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
GlobeNewswire
·
August 26, 2025
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-saving medical products is pleased to provide the following update …
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
GlobeNewswire
·
August 26, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announces that it has successfully identified a new biological target and novel therapeutic indication for its lead …
Adagene to Participate in Two Investor Conferences in September
GlobeNewswire
·
August 26, 2025
SAN DIEGO and SUZHOU, China, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Strategy …
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
GlobeNewswire
·
August 26, 2025
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to be Featured in Presentation by Dr. Sobha Sivaprasad - …
Proxygen and EPFL Launch Strategic Collaboration to Advance AI-Driven Glue Discovery
GlobeNewswire
·
August 26, 2025
VIENNA and LAUSANNE, Switzerland, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Proxygen, a global leader in the discovery and development of molecular glue degraders, today announced a strategic research collaboration with EPFL (the Swiss Federal Institute of …
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer
GlobeNewswire
·
August 26, 2025
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor …
Nasus Pharma Marks NYSE American Listing with Bell Ringing Ceremony
GlobeNewswire
·
August 26, 2025
TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
Compass Therapeutics to Participate in Upcoming September Investor Events
GlobeNewswire
·
August 26, 2025
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
GlobeNewswire
·
August 26, 2025
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Ashvattha Therapeutics to Present Late-Breaking Phase 2 DME and nAMD Data at 25th EURETINA Congress
GlobeNewswire
·
August 26, 2025
Company to present topline 40-week Phase 2 study efficacy and safety results of migaldendranib (MGB), a novel first-in-class nanomedicine for DME and nAMD Subcutaneous at-home administration represents a potential paradigm shift from frequent in-office …
PharmaTher Provides Corporate Update Following FDA Approval of Ketamine (KETARx™)
GlobeNewswire
·
August 26, 2025
TORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to provide a …
InnovAge to Announce Fourth Quarter and Fiscal 2025 Financial Results and Host Conference Call Tuesday, September 9, 2025
GlobeNewswire
·
August 26, 2025
DENVER, Aug. 26, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All- …
Global Healthcare Dispensing Systems Market to Reach USD 6.27 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 26, 2025
Delray Beach, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating …